3 Appendix 1, Regulation (EU) 2017/735

In forcesince 14 Feb 2017

Aneuploidyany deviation from the normal diploid (or haploid) number of chromosomes by a single chromosome or more than one, but not by entire set(s) of chromosomes (polyploidy).

Apoptosisprogrammed cell death characterised by a series of steps leading to a disintegration of cells into membrane-bound particles that are then eliminated by phagocytosis or by shedding.

Cell proliferationincrease in cell number as a result of mitotic cell division.

Chemicala substance or a mixture.

Chromatid breakdiscontinuity of a single chromatid in which there is a clear misalignment of one of the chromatids.

Chromatid gapnon-staining region (achromatic lesion) of a single chromatid in which there is minimal misalignment of the chromatid.

Chromatid-type aberrationstructural chromosome damage expressed as breakage of single chromatids or breakage and reunion between chromatids.

Chromosome-type aberrationstructural chromosome damage expressed as breakage, or breakage and reunion, of both chromatids at an identical site.

Clastogenany chemical which causes structural chromosomal aberrations in populations of cells or eukaryotic organisms.

Concentrationsrefer to final concentrations of the test chemical in the culture medium.

CytotoxicityFor the assays covered in this test method using cell lines, cytotoxicity is identified as a reduction in relative population doubling (RPD) or relative increase in cell count (RICC) of the treated cells as compared to the negative control (see paragraph 17 and Appendix 2). For the assays covered in this test method using primary cultures of lymphocytes, cytotoxicity is identified as a reduction in mitotic index (MI) of the treated cells as compared to the negative control (see paragraph 18 and Appendix 2).

Endoreduplicationa process in which after an S period of DNA replication, the nucleus does not go into mitosis but starts another S period. The result is chromosomes with 4, 8, 16…, chromatids.

Genotoxica general term encompassing all types of DNA or chromosome damage, including breaks, deletions, adducts, nucleotides modifications and linkages, rearrangements, gene mutations, chromosome aberrations, and aneuploidy. Not all types of genotoxic effects result in mutations or stable chromosome damage.

Mitotic index (MI)the ratio of cells in metaphase divided by the total number of cells observed in a population of cells; an indication of the degree of proliferation of that population.

Mitosisdivision of the cell nucleus usually divided into prophase, prometaphase, metaphase, anaphase and telophase.

Mutagenicproduces a heritable change of DNA base-pair sequences(s) in genes or of the structure of chromosomes (chromosome aberrations).

Numerical aberrationa change in the number of chromosomes from the normal number characteristic of the cells utilised.

Polyploidynumerical chromosomal aberrations in cells or organisms involving entire set(s) of chromosomes, as opposed to an individual chromosome or chromosomes (aneuploidy).

p53 statusp53 protein is involved in cell cycle regulation, apoptosis and DNA repair. Cells deficient in functional p53 protein, unable to arrest cell cycle or to eliminate damaged cells via apoptosis or other mechanisms (e.g. induction of DNA repair) related to p53 functions in response to DNA damage, should be theoretically more prone to gene mutations or chromosomal aberrations.

Relative Increase in Cell Counts (RICC)the increase in the number of cells in chemically-exposed cultures versus increase in non-treated cultures, a ratio expressed as a percentage.

Relative Population Doubling (RPD)the increase in the number of population doublings in chemically-exposed cultures versus increase in non-treated cultures, a ratio expressed as a percentage.

S9 liver fractionsupernatant of liver homogenate after 9000 g centrifugation, i.e. raw liver extract.

S9 mixmix of the S9 liver fraction and cofactors necessary for metabolic enzymes activity.

Solvent controlGeneral term to define the control cultures receiving the solvent alone used to dissolve the test chemical.

Structural aberrationa change in chromosome structure detectable by microscopic examination of the metaphase stage of cell division, observed as deletions and fragments, intrachanges or interchanges.

Test chemicalAny substance or mixture tested using this test method.

Untreated controlscultures that receive no treatment (i.e. no test chemical nor solvent) but are processed concurrently in the same way as the cultures receiving the test chemical.